Citi Trends Inc: Form 10-Q for the period ended Oct 29, 2022
Filed with the SEC on Dec 8, 2022 and accepted by EDGAR at Dec 8, 2022, 11:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-10-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-31 to 2022-10-29 | $192.3m | us-gaap:Revenues |
| Revenue | 9 months2022-01-30 to 2022-10-29 | $585.5m | us-gaap:Revenues |
| Selling, general and administrative | 3 months2022-07-31 to 2022-10-29 | $69.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-01-30 to 2022-10-29 | $208.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-07-31 to 2022-10-29 | $31.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-30 to 2022-10-29 | $67.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-07-31 to 2022-10-29 | $76.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2022-01-30 to 2022-10-29 | $230.0k | us-gaap:InterestExpense |
| Income tax | 3 months2022-07-31 to 2022-10-29 | $7.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-30 to 2022-10-29 | $15.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-31 to 2022-10-29 | $24.6m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months2022-01-30 to 2022-10-29 | $52.3m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2022-07-31 to 2022-10-29 | $3.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-01-30 to 2022-10-29 | $6.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-07-31 to 2022-10-29 | $3.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-30 to 2022-10-29 | $6.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-07-31 to 2022-10-29 | 8,145,318 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-01-30 to 2022-10-29 | 8,236,836 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-01-30 to 2022-10-29 | −$23.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-01-30 to 2022-10-29 | $19.2m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 9 months2022-01-30 to 2022-10-29 | $10.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2022-10-29 | $219.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-10-29 | $546.9m | us-gaap:Assets |
| Current liabilities | At period end2022-10-29 | $163.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-10-29 | $388.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-10-29 | $158.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-22-018469. Last ingested by Listed: Oct 27, 2026, 17:26 ET. Listed shows no prices and gives no investment advice.